Sfoglia per Autore
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease
2015-01-01 Brunetto, Mr; Xia, Ns; Shih, Jw; Bonino, F; Ricco, Gabriele; Coco, Ba; Oliveri, F; Colombatto, P; Cherubini, B; Moriconi, F; Cavallone, D; Song, Lw; Yuan, Q.
A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C.
2015-01-01 Iannazzo, S; Colombatto, P; Ricco, Gabriele; Oliveri, F; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases
2016-01-01 Brunetto, MAURIZIA ROSSANA; Miyamura, T; Wakita, T; Li, Tc; Galli, C; Romanò, L; Mascolo, G; Marchisio, E; Messa, P; Alfieri, Cm; Scatena, F; Lanza, M; Bonino, Ferruccio; Ricco, Gabriele
Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
2018-01-01 Ricco, Gabriele; Popa, Dc; Cavallone, D; Iacob, S; Salvati, A; Tabacelia, D; Oliveri, F; Mascolo, Giancarlo; Bonino, F; Yuan, Q; Xia, Ns; Gheorghe, L; Brunetto, Mr.
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma.
2020-01-01 Ricco, G; Cosma, C; Bedogni, G; Biasiolo, A; Guarino, M; Pontisso, P; Morisco, F; Oliveri, F; Cavallone, D; Bonino, F; Plebani, M; Brunetto, Mr.
Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
2020-01-01 Cavallone, D; Ricco, G; Oliveri, F; Colombatto, P; Moriconi, F; Coco, B; Romagnoli, V; Salvati, A; Surace, L; Bonino, F; Brunetto, Mr
Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index
2022-01-01 Demirtas, Co; Ricco, G; Ozdogan, Oc; Baltacioglu, F; Ones, T; Yumuk, Pf; Dulundu, E; Uzun, S; Colombatto, P; Oliveri, F; Brunetto, Mr; Gunduz, F
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
2022-01-01 Colombatto, Piero; Palmisano, Elena; Ricco, Gabriele; Cavallone, Daniela; Oliveri, Filippo; Coco, Barbara; Salvati, Antonio; Romagnoli, Veronica; Surace, Lidia; Vatteroni, Marialinda; Pistello, Mauro; Virdis, Agostino; Bonino, Ferruccio; Brunetto, Maurizia Rossana
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
2023-01-01 Cavallone, D; Ornos, Edb; Ricco, G; Oliveri, F; Coco, B; Colombatto, P; De Rosa, L; Dalmacio, Lmm; Bonino, F; Brunetto, Mr.
Highly dynamic changes of regional HBV epidemiology over two decades.
2023-01-01 Ricco, G; Coco, B; Colombatto, P; Oliveri, F; Cavallone, D; Bleve, P; Vianello, B; Romagnoli, V; Salvati, A; Surace, L; Bonino, F; Brunetto, Mr.
EASLClinical Practice Guidelines on hepatitis delta virus.
2023-01-01 Brunetto, MAURIZIA ROSSANA; Ricco, Gabriele; Agharwal, Kosh; Asselah, Tarik; Farci, Patrizia; Gheorghe, Liana; Negro, Francesco; Papatheodoridis, George; Wedemeyer, Heiner; Yurdaydin, Cihan; Buti, Maria
Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease
2023-01-01 Petralli, Giovanni; Salvati, Antonio; Tricò, Domenico; Ricco, Gabriele; Colombatto, Piero; Brunetto, Maurizia Rossana; Solini, Anna
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease | 1-gen-2015 | Brunetto, Mr; Xia, Ns; Shih, Jw; Bonino, F; Ricco, Gabriele; Coco, Ba; Oliveri, F; Colombatto, P; Cherubini, B; Moriconi, F; Cavallone, D; Song, Lw; Yuan, Q. | |
| A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C. | 1-gen-2015 | Iannazzo, S; Colombatto, P; Ricco, Gabriele; Oliveri, F; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA | |
| New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases | 1-gen-2016 | Brunetto, MAURIZIA ROSSANA; Miyamura, T; Wakita, T; Li, Tc; Galli, C; Romanò, L; Mascolo, G; Marchisio, E; Messa, P; Alfieri, Cm; Scatena, F; Lanza, M; Bonino, Ferruccio; Ricco, Gabriele | |
| Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection. | 1-gen-2018 | Ricco, Gabriele; Popa, Dc; Cavallone, D; Iacob, S; Salvati, A; Tabacelia, D; Oliveri, F; Mascolo, Giancarlo; Bonino, F; Yuan, Q; Xia, Ns; Gheorghe, L; Brunetto, Mr. | |
| Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma. | 1-gen-2020 | Ricco, G; Cosma, C; Bedogni, G; Biasiolo, A; Guarino, M; Pontisso, P; Morisco, F; Oliveri, F; Cavallone, D; Bonino, F; Plebani, M; Brunetto, Mr. | |
| Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection? | 1-gen-2020 | Cavallone, D; Ricco, G; Oliveri, F; Colombatto, P; Moriconi, F; Coco, B; Romagnoli, V; Salvati, A; Surace, L; Bonino, F; Brunetto, Mr | |
| Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index | 1-gen-2022 | Demirtas, Co; Ricco, G; Ozdogan, Oc; Baltacioglu, F; Ones, T; Yumuk, Pf; Dulundu, E; Uzun, S; Colombatto, P; Oliveri, F; Brunetto, Mr; Gunduz, F | |
| Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy | 1-gen-2022 | Colombatto, Piero; Palmisano, Elena; Ricco, Gabriele; Cavallone, Daniela; Oliveri, Filippo; Coco, Barbara; Salvati, Antonio; Romagnoli, Veronica; Surace, Lidia; Vatteroni, Marialinda; Pistello, Mauro; Virdis, Agostino; Bonino, Ferruccio; Brunetto, Maurizia Rossana | |
| The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection | 1-gen-2023 | Cavallone, D; Ornos, Edb; Ricco, G; Oliveri, F; Coco, B; Colombatto, P; De Rosa, L; Dalmacio, Lmm; Bonino, F; Brunetto, Mr. | |
| Highly dynamic changes of regional HBV epidemiology over two decades. | 1-gen-2023 | Ricco, G; Coco, B; Colombatto, P; Oliveri, F; Cavallone, D; Bleve, P; Vianello, B; Romagnoli, V; Salvati, A; Surace, L; Bonino, F; Brunetto, Mr. | |
| EASLClinical Practice Guidelines on hepatitis delta virus. | 1-gen-2023 | Brunetto, MAURIZIA ROSSANA; Ricco, Gabriele; Agharwal, Kosh; Asselah, Tarik; Farci, Patrizia; Gheorghe, Liana; Negro, Francesco; Papatheodoridis, George; Wedemeyer, Heiner; Yurdaydin, Cihan; Buti, Maria | |
| Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease | 1-gen-2023 | Petralli, Giovanni; Salvati, Antonio; Tricò, Domenico; Ricco, Gabriele; Colombatto, Piero; Brunetto, Maurizia Rossana; Solini, Anna |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile